Company logo

FMS - Fresenius Medical Care AG & Co. KGaA

NYSE -> Healthcare -> Medical Care Facilities
Bad Homburg, Germany
Type: Equity

FMS price evolution
FMS
(in millions $) 31 Jan 2024 30 Oct 2023 30 Jul 2023 1 May 2023
Current assets
Cash
Short term investments
Net receivables $3714.23 $3646.05 $3995.29
Inventory $2303.9 $2335.44 $2328.03
Total current assets $9054.21 $8347.01 $8561.72
Long term investments
Property, plant & equipment $7885.47 $7930.77 $8081.88
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $35634.7 $34960.14 $35500.51
Current liabilities
Accounts payable $753.12 $720.31 $822.34
Deferred revenue
Short long term debt
Total current liabilities $6619.33 $6624.18 $6491.84
Long term debt $11067.1 $10808.27 $11197.91
Total noncurrent liabilities
Total debt
Total liabilities $21628.14 $21431.92 $21672.61
Shareholders' equity
Retained earnings $10759.2 $10643.22 $10851.42
Other shareholder equity -$424.13 -$779.54 -$682.02
Total shareholder equity
(in millions $) 31 Jan 2024 31 Jan 2023 30 Dec 2021 30 Dec 2020
Current assets
Cash $911.01 $1481.65 $1081.54
Short term investments $159.18 $179.26
Net receivables $3882.04 $3906.68 $3619.04
Inventory $2296.21 $2038.01 $1895.31
Total current assets $8203.45 $7967.24 $7275.31
Long term investments $786.9 $761.11
Property, plant & equipment $8339.81 $8551.47 $8186.75
Goodwill & intangible assets
Total noncurrent assets $27887.8
Total investments
Total assets $35754.11 $34366.56 $31689.04
Current liabilities
Accounts payable $813.25 $818.51 $794.93
Deferred revenue
Short long term debt $667.97 $1008.36
Total current liabilities $6467.31 $7257.63 $6159.64
Long term debt $11175.67 $6646.95 $6800.1
Total noncurrent liabilities $15076.17
Total debt
Total liabilities $21764.66 $20387.52 $19357.73
Shareholders' equity
Retained earnings $10711.71 $10826.14 $10254.91
Other shareholder equity -$388.47 -$1311.64 -$2205.34
Total shareholder equity $12698.78 $11215.08
(in millions $) 31 Jan 2024 30 Oct 2023 30 Jul 2023 1 May 2023
Revenue
Total revenue $4825.28
Cost of revenue
Gross Profit $1197.21
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $888.85
Operating income
Income from continuing operations
EBIT
Income tax expense $81.14
Interest expense -$32.27
Net income
Net income $140.36
Income (for common shares)
(in millions $) 31 Jan 2024 31 Jan 2023 31 Jan 2022 30 Dec 2020
Revenue
Total revenue $19454 $19398.02 $17859.06
Cost of revenue $12321.62
Gross Profit $4925 $5310.25 $5537.44
Operating activities
Research & development $193.77
Selling, general & administrative $2996.44
Total operating expenses $3678 $3757.49 $15511.83
Operating income $2347.23
Income from continuing operations
EBIT $2347.23
Income tax expense $301 $324.95 $500.56
Interest expense -$214 -$322.34 -$409.98
Net income
Net income $499 $673.4 $1164.38
Income (for common shares) $1164.38
(in millions $) 30 Oct 2023 30 Jul 2023 1 May 2023 31 Jan 2023
Net income
Operating activities
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations
Investing activities
Capital expenditures
Investments
Total cash flows from investing -$447.73 -$296.62 -$163.28 -$734.73
Financing activities
Dividends paid -$328.62 -$328.62 -$395.56
Sale and purchase of stock
Net borrowings
Total cash flows from financing -$1112.88 -$700.54 $2.01 -$1617.36
Effect of exchange rate -$48.56 -$65.3 -$31.47 -$23.16
Change in cash and equivalents $300.57 $87.51 -$49.9 -$207.87
(in millions $) 31 Jan 2023 30 Dec 2021 30 Dec 2020 30 Dec 2019
Net income $969.31 $1164.38 $1199.62
Operating activities
Depreciation $1535.58 $1543.55 $1524.69
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations $2489.5 $4233.16 $2566.95
Investing activities
Capital expenditures -$854.36 -$1051.98 -$1124.79
Investments -$61.58 -$65.06 -$17.98
Total cash flows from investing -$734.73 -$1196.23 -$1334.94 -$3285.99
Financing activities
Dividends paid -$395.56 -$392.45 -$351.17 -$354.64
Sale and purchase of stock
Net borrowings -$358.9 -$1639.83 $699.98
Total cash flows from financing -$1617.36 -$1024.38 -$2664.03 -$466.63
Effect of exchange rate -$23.16 $131.23 -$160.37 $47.76
Change in cash and equivalents -$207.87 $400.12 $73.82 -$1137.91
Fundamentals
Market cap N/A
Enterprise value N/A
Shares outstanding N/A
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Current ratio N/A
Quick ratio N/A